MEK-ERK Pathway

Known as: Pathway, MEK-ERK, MEK-ERK Pathways, MEK ERK Pathway 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2018
0119802018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
In den letzten Jahren kam es bezüglich der systemischen Therapie des metastasierten malignen Melanoms durch die Einführung der… (More)
Is this relevant?
2017
2017
Mesenchymal-type cancers after epithelial mesenchymal transition (EMT) were recently shown to acquire chemoresistance through… (More)
Is this relevant?
Review
2016
Review
2016
Die medikamentöse Behandlung des inoperabel metastasierten Melanoms hat sich in den letzten Jahren durch die Entwicklung neuer… (More)
Is this relevant?
Review
2012
Review
2012
Während das maligne Melanom (MM) im frühen Stadium eine günstige Prognose aufweist, liegt die 5-Jahres-Überlebensrate bei… (More)
Is this relevant?
2011
2011
e21012 Background: NSCLC is the most common cause of cancer-related death. Platinum-based chemotherapy is the mainstay of… (More)
Is this relevant?
2007
2007
OBJECTIVE We previously demonstrated that that the Ras/ER/MDM2 pathway was critical for NIH3T3 cell transformation. In this study… (More)
Is this relevant?
Review
2005
Review
2005
Protein kinase B (Akt) plays an essential role in the actions of insulin, cytokines and growth factors, although the substrates… (More)
  • figure 3
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
Review
1980
Review
1980
An historical prospective study was undertaken of 262 men who had worked on an isopropyl alcohol plant and 446 men who had worked… (More)
Is this relevant?